论文信息 - 18F-Fluoride (18F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines! - 字舞流文

18F-Fluoride (18F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines!

L. Giovanella | G. Treglia

[1] P. Duarte. Letter to the Editor: 18F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[2] M. Luster,et al. EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[3] Fares Alahdab,et al. New evidence pyramid , 2016, Evidence-Based Medicine.

[4] B. Krause,et al. The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the “evidence-based” refusal to endorse them by EANM due to the “not evidence-based” marginalization of the role of Nuclear Medicine , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[5] G. Antes,et al. Bias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensus , 2016, BMJ Open.

[6] Douglas B. Evans,et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.